Search research articles
Contact Us
Filters
Showing results (1-10 of 66) with videos related to
Page
of 7
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
June 14, 2017
Treating to Target in Older Hypertensive Patients: Where Is the Bull's Eye?
Gary L Schwartz
Endocrinology and Metabolism Clinics of North America
|
May 14, 2011
Screening for adrenal-endocrine hypertension: overview of accuracy and cost-effectiveness
Gary L Schwartz
Mayo Clinic Proceedings
|
February 5, 2013
Proper evaluation of asymptomatic microscopic hematuria in the era of evidence-based medicine--progress is being made
Gary L Schwartz
American Journal of Hypertension
|
November 18, 2024
Age and Comorbidities May Affect the Relationship Between Pulse Pressure and Adverse Outcomes
Kambiz Kalantari, Gary L Schwartz
Journal of the American Society of Nephrology : JASN
|
July 22, 2017
BP Targets in CKD, Mortality, and SPRINT: What Have We Learned?
Stephen C Textor, Gary L Schwartz
Current Hypertension Reports
|
February 3, 2005
Gene markers and antihypertensive therapy
Stephen T Turner, Gary L Schwartz
Mayo Clinic Proceedings
|
November 24, 2006
Early referral for chronic kidney disease: good for those who need it, but who are they?
Gary L Schwartz, Stephen C Textor
American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice
|
June 4, 2004
Pharmacogenetics of antihypertensive drug responses
Gary L Schwartz, Stephen T Turner
Clinical Chemistry
|
February 1, 2005
Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity
Gary L Schwartz, Stephen T Turner
Journal of the American Society of Hypertension : JASH
|
September 17, 2014
Diagnostic evaluation: Initial evaluation: laboratory testing
Gary L Schwartz, Lawrence R Krakoff
Page
of 7
Search research articles
Search
Showing results (1-10 of 66) with videos related to
Sort By:
Page
of 7
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
June 14, 2017
Treating to Target in Older Hypertensive Patients: Where Is the Bull's Eye?
Gary L Schwartz
Endocrinology and Metabolism Clinics of North America
|
May 14, 2011
Screening for adrenal-endocrine hypertension: overview of accuracy and cost-effectiveness
Gary L Schwartz
Mayo Clinic Proceedings
|
February 5, 2013
Proper evaluation of asymptomatic microscopic hematuria in the era of evidence-based medicine--progress is being made
Gary L Schwartz
American Journal of Hypertension
|
November 18, 2024
Age and Comorbidities May Affect the Relationship Between Pulse Pressure and Adverse Outcomes
Kambiz Kalantari, Gary L Schwartz
Journal of the American Society of Nephrology : JASN
|
July 22, 2017
BP Targets in CKD, Mortality, and SPRINT: What Have We Learned?
Stephen C Textor, Gary L Schwartz
Current Hypertension Reports
|
February 3, 2005
Gene markers and antihypertensive therapy
Stephen T Turner, Gary L Schwartz
Mayo Clinic Proceedings
|
November 24, 2006
Early referral for chronic kidney disease: good for those who need it, but who are they?
Gary L Schwartz, Stephen C Textor
American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice
|
June 4, 2004
Pharmacogenetics of antihypertensive drug responses
Gary L Schwartz, Stephen T Turner
Clinical Chemistry
|
February 1, 2005
Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity
Gary L Schwartz, Stephen T Turner
Journal of the American Society of Hypertension : JASH
|
September 17, 2014
Diagnostic evaluation: Initial evaluation: laboratory testing
Gary L Schwartz, Lawrence R Krakoff
Page
of 7